Skip to main content
European Commission logo
Cancer Screening, Diagnosis and Care

ECIBC working groups

ECIBC is supported by two working groups composed of physicians, epidemiologists, researchers, patient representatives, and other experts who joined the project on a voluntary basis upon public calls launched in 2014.

Members

The members have signed declarations on confidentiality and commitment, and they submit annually a declaration of interests relevant for the project.

The two working groups supporting ECIBC are:

  • The Guidelines Development Group (GDG) for the European guidelines on breast cancer screening and diagnosis,
  • The Quality Assurance Scheme Development Group (QASDG) for the European quality assurance scheme for breast cancer services.

Meetings

  1. May 2024
    GDG

    Fourth update of the European breast cancer guidelines: discussion on the screening tests for women with high breast density.

  2. December 2023
    GDG

    Information session: discussion on the ongoing update of the European breast cancer guidelines.

  3. July 2023
    QASDG

    Overview and discussion on the updates to the service requirements, the scheme documents and the supporting materials.

  4. July 2023
    GDG

    Fourth update of the European breast cancer guidelines: discussion and voting on new recommendations on the use of artificial intelligence for reading mammograms.

  5. May 2023
    GDG

    Fourth update of the European breast cancer guidelines: discussion and voting on new recommendations on the use of tomosynthesis in screening for average-risk and women with high breast density.

  6. March 2023
    QASDG

    Discussion on amendments to service requirements following testing in real settings.

  7. March 2023
    QASDG CERTIFICATION SUBGROUP

    Discussion on certification requirements.

  8. December 2022
    GDG

    Discussion on risk stratification in breast cancer screening.
    Discussion on the next update of the European breast cancer guidelines.

  9. 3 October 2022
    QASDG

    Discussion on the testing of the European QA scheme.

  10. 30 June 2022
    QASDG

    Discussion on the testing of the European QA scheme.

  11. 9 March 2022
    QASDG CERTIFICATION SUBGROUP

    Discussion on the testing of the European QA scheme.

  12. 17 February 2022
    GDG

    Third update of the European breast cancer guidelines: discussion and voting on new recommendations on the use of artificial intelligence for reading mammograms.

  13. 4 February 2022
    GDG

    Third update of the European breast cancer guidelines: discussion and voting on new recommendations on the use of artificial intelligence for reading mammograms.

  14. November 2021
    GDG

    Third update of the European breast cancer guidelines: discussion on risk assessment models for breast cancer.

  15. October 2021
    GDG

    Third update of the European breast cancer guidelines: discussion and voting on recommendations on the use of CEM for planning surgical treatment.

  16. September 2021
    GDG

    Third update of the European breast cancer guidelines: discussion and voting on recommendations on screening women aged 45-49 and tailored screening for women with high breast density.

  17. June 2021
    GDG

    Third update of the European breast cancer guidelines: discussion and voting on recommendations on the use of tomosynthesis in screening and decision aids to inform women about the benefits and harms.

  18. September 2020
    QASDG CERTIFICATION SUBGROUP

    Discussions on scheme owner manual.

  19. July 2020
    QASDG

    Discussions and voting on quality assurance requirements for screening, diagnosis, imaging, pathology and training for professionals.

  20. March 2020
    QASDG CERTIFICATION SUBGROUP

    Discussions on recognition of existing certification schemes, step-wise approach and how networks of cancer services can operate under the QA scheme.

  21. January 2020
    GDG

    Second update of the European breast cancer guidelines: discussion and voting on recommendations on the use of tomosynthesis in screening and tailored screening for women with high breast density.

  22. May 2019
    QASDG, GDG

    Discussion and voting on recommendations on communication skills training for healthcare professionals, and the use of decision aids. Discussion on quality assurance requirements and indicators.

  23. November 2018
    QASDG, GDG

    Discussion and voting on recommendations on the use of CESM for surgical treatment planning, multigene testing to guide the use of chemotherapy, and optimal number of readings per radiologists. Update of recommendations on the use of tomosynthesis in screening. Data-set for computing indicators and requirements for training of auditors and auditees.

  24. September 2018
    GDG

    Discussion and voting on recommendations on the use of electronic means to invite women to organised screening programmes, use of PET-CT for staging.

  25. June 2018
    QASDG, GDG

    Discussion and voting on recommendations on communicating women about screening results, and invitation strategies for subsequent rounds or further assessment. Discussion and voting on quality assurance requirements and indicators.

  26. April 2018
    QASDG

    Discussion and voting on quality assurance requirements and indicators.

  27. February 2018
    QASDG

    Discussion on quality assurance requirements, indicators on diagnosis, training and certification.

  28. November 2017
    QASDG, GDG

    Discussion and voting on recommendations on organised screening programmes, use of double-reading, and use of clip-marking for planning surgical treatment. Discussion and voting on quality assurance requirements and indicators.

  29. September 2017
    QASDG, GDG

    Subgroup discussions on recommendations and quality assurance requirements.

  30. May 2017
    GDG

    Discussion and voting on recommendations on invitation strategies for the general and vulnerable populations, and training for healthcare professionals.

  31. February 2017
    QASDG, GDG

    Discussion and voting on recommendations on screening frequencies, tailored screening for women with high breast density, invitation strategies, and type of biopsy to diagnose breast cancer. Discussion and voting on quality assurance requirements and indicators.

  32. November 2016
    QASDG, GDG

    Discussion and voting on recommendations on screening ages and thematic meetings on testing and imaging

  33. September 2016
    QASDG, GDG

    Subgroup meetings

  34. June 2016
    QASDG, GDG

    Set-up of methodological frameworks

  35. March 2016
    QASDG, GDG

    Approval of the scopes

  36. December 2015
    QASDG, GDG

    Organisation of thematic subgroups

  38. September 2015
    QASDG, GDG

    Kick-off meeting

Documents

Original call for working group members GDG
English
(162 kB - PDF)

Download 

Original call for working group members QASDG
English
(167 kB - PDF)

Download 

Rules of procedure agreed by the working groups
English
(378 kB - PDF)

Download 

Declarations of confidentiality and commitment signed by each member
English
(260 kB - PDF)

Download 

Declaration of interests filled in and signed by each member
English
(260 kB - PDF)

Download 

Guidance to disclose interests
English
(383 kB - PDF)

Download 

Assessment and management of interests. Rules and criteria to assess and manage conflicts of interests
English
(649 kB - PDF)

Download 

Privacy statement for applicants/members
English
(556 kB - PDF)

Download